Patent · US Active

Compositions for the in vitro derivation and culture of embryonic stem (ES) cell lines with germline transmission capability and for the culture of adult stem cells

US8697444B2 · kind B2 · utility

11Cited by
9References
11Claims
0Family size

Assignee

Inventor

Key dates

Filing dateNov 20, 2008
Grant dateApr 15, 2014
Priority date
Expiry dateNov 29, 2030

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12N2502/99
  • WIPO fieldPharmaceuticals
  • WIPO sectorChemistry

Abstract

The present invention encompasses compositions for deriving, maintaining, and growing pluripotent and germ-line competent mammalian embryonic stem cells, and for deriving, maintaining, and growing adult human stem cells and/or adult early progenitor cells. Such compositions comprising a conditioned medium of a cell line expressing limited amounts of Leukemia Inhibitory Factor (LIF). The media of the present invention are used or for the generation of pluripotent and germ-line competent embryonic stem cells of mammals, and for the generation of adult human stem cells and/or adult early progenitor cells.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.